Acquisition of Exclusive Medicines

This tender pertains to the procurement of 'exclusive medicines'. This term typically refers to pharmaceutical products that are protected by patents, are newly developed, or are the sole available treatment option for specific conditions, often carrying high costs. The acquisition process for such medicines requires careful consideration of market exclusivity, therapeutic value, and cost-effectiveness. The tender will likely involve detailed specifications of the medicines required, including their indications, dosages, and required therapeutic outcomes. Bidders are expected to be the authorized suppliers or manufacturers of these exclusive pharmaceutical products. The objective is to ensure access to these vital, often specialized, medications for patients who depend on them, while potentially negotiating favorable terms due to their exclusive nature. The tender documentation will outline the specific requirements and evaluation criteria for this specialized procurement.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 4,475.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.